(Total Views: 592)
Posted On: 12/26/2020 9:51:34 AM
Post# of 153911
Re: KenChowder #69732
“I don't think your question makes any sense.”
I agree, I don’t think it makes sense either, and that’s why a proposed the question.
“The trial is blinded to Cytodyn, and the results of the earlier EINDs are anecdotal, so the company couldn't possibly offer efficacy data. Which would mean there would be no point in providing guidance for open label.”
Exactly the point of my post. The S/C data is blinded and I don’t believe the FDA hasn’t seen the data.
I agree, I don’t think it makes sense either, and that’s why a proposed the question.
“The trial is blinded to Cytodyn, and the results of the earlier EINDs are anecdotal, so the company couldn't possibly offer efficacy data. Which would mean there would be no point in providing guidance for open label.”
Exactly the point of my post. The S/C data is blinded and I don’t believe the FDA hasn’t seen the data.
(1)
(0)
